Prognostic significance of interim 18F‐fluorodeoxyglucose positron emission tomography–computed tomography volumetric parameters in metastatic or recurrent gastric cancer
- 10 December 2017
- journal article
- research article
- Published by Wiley in Asia-Pacific Journal of Clinical Oncology
- Vol. 14 (5) , e302-e309
Abstract
Aim: To evaluate the prognostic role of interim analysis of 18F‐fluorodeoxyglucose (FDG) positron emission tomography–computed tomography (PET/CT) volumetric parameters in patients with recurrent or metastatic advanced gastric cancer (AGC) treated with fluoropyrimidine‐based palliative chemotherapy.Methods: Forty‐four patients who underwent baseline and interim PET/CT scanning during palliative chemotherapy were analyzed retrospectively. Initial and change of metabolic parameters (MP) – metabolic tumor volume (MTV), tumor lesion glycolysis (TLG) and maximum and mean standardized uptake values (SUV) were measured with PET/CT. Metabolic change was measured by ∆MP (%) = (MPinterim − MPinitial)/MP initial × 100. Independent t‐test was employed to compare values of initial, interim and change of metabolic parameters between each response group. Log‐rank test was employed for univariate analysis, and multivariate analysis was performed using the Cox proportional hazards regression model to determine independently significant prognostic factors.Results: Reduced percentage values of maximum and mean SUV on interim PET/CT and initial values of volumetric parameters (MTV and TLG) were significant predicting factors to response to fluoropyrimidine‐based palliative chemotherapy. The decreased percentage values of metabolic parameters as well as maximum and mean SUV with receiver operating characteristic (ROC) curve determined cut‐off points were significant prognostic factors for overall survival and progression‐free survival in univariate and multivariate analyses.Conclusion: Measurement of metabolic decrease of volumetric parameters by interim PET/CT analysis is useful to determine the prognosis of patients with recurrent or metastatic AGC.Keywords
This publication has 38 references indexed in Scilit:
- Prognostic significance of metabolic tumor volume in patients with piriform sinus carcinoma treated by radiotherapy with or without concurrent chemotherapyHead & Neck, 2016
- Prognostic value of volumetric parameters of 18F-FDG PET in non-small-cell lung cancer: a meta-analysisEuropean Journal of Nuclear Medicine and Molecular Imaging, 2014
- Pretreatment F-18 FDG PET/CT Parameters to Evaluate Progression-Free Survival in Gastric CancerNuclear Medicine and Molecular Imaging, 2013
- Predictive and prognostic value of metabolic tumour volume and total lesion glycolysis in solid tumoursEuropean Journal of Nuclear Medicine and Molecular Imaging, 2012
- A prospective evaluation of the utility of 2‐deoxy‐2‐[18F]fluoro‐D‐glucose positron emission tomography and computed tomography in staging locally advanced gastric cancerCancer, 2012
- Predictive value of pretreatment metabolic activity measured by fluorodeoxyglucose positron emission tomography in patients with metastatic advanced gastric cancer: the maximal SUV of the stomach is a prognostic factorEuropean Journal of Nuclear Medicine and Molecular Imaging, 2012
- Prognostic value of 18F‐FDG PET/CT in patients with squamous cell carcinoma of the tonsil: Comparisons of volume‐based metabolic parametersHead & Neck, 2012
- High FDG uptake in PET/CT predicts worse prognosis in patients with metastatic gastric adenocarcinomaJournal of Cancer Research and Clinical Oncology, 2010
- The predictive value of 18F-FDG-PET early evaluation in patients with metastatic gastric adenocarcinoma treated with chemotherapy plus cetuximabGastric Cancer, 2007
- FDG PET imaging of locally advanced gastric carcinomas: correlation with endoscopic and histopathological findingsEuropean Journal of Nuclear Medicine and Molecular Imaging, 2003